Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage

Background and Purpose— The purpose of the study was to evaluate the effect of APOE genotype and the feasibility of administering an apolipoprotein E-mimetic therapeutic to modify outcomes in a murine model of intracerebral hemorrhage. Methods— Intracerebral hemorrhage was induced via stereotactic injection of 0.1 U Clostridial collagenase into the left basal ganglia of wild-type and apolipoprotein-E targeted-replacement mice, consisting of either homozygous 3/3 or 4/4 genotypes. Animals were randomized to receive either vehicle or apolipoprotein E-mimetic peptide. Outcomes included functional neurological tests (21-point neuroseverity score and Rotorod latency) over the initial 7 days after injury, radiographic and histological hemorrhage size at 3 and 7 days, brain water content for cerebral edema at 24 hours, and quantitative polymerase chain reaction for inflammatory markers at 6, 24, and 48 hours. Results— Apolipoprotein-E targeted-replacement mice consisting of homozygous 3/3 demonstrated superior neuroseverity scores and Rotorod latencies over the first 3 days after intracerebral hemorrhage, decreased cerebral edema at 24 hours, and reduced upregulation of IL-6 and endothelial nitric oxide synthase at 6 hours when compared to their apolipoprotein-E targeted-replacement mice consisting of homozygous 4/4 counterparts. After intravenous administration of 1 mg/kg apolipoprotein E-mimetic peptide, both wild-type and apolipoprotein-E targeted-replacement mice consisting of homozygous 4/4 exhibited improved functional outcomes over 7 days after intracerebral hemorrhage, less edema at 24 hours, and reduced upregulation of IL-6 and endothelial nitric oxide synthase when compared to mice that did not receive the peptide. Conclusions— Our data indicate that APOE genotype influences neurological outcome after intracerebral hemorrhage in a murine model. In particular APOE4 is associated with poor functional outcome and increased cerebral edema. Additionally, this outcome can be modified by the addition of an apolipoprotein E mimetic-peptide, COG1410.

[1]  M. Woodward,et al.  APOE genotype, ethnicity, and the risk of cerebral hemorrhage , 2008, Neurology.

[2]  D. Warner,et al.  Preclinical Models of Intracerebral Hemorrhage: A Translational Perspective , 2008, Neurocritical care.

[3]  Michael P Vitek,et al.  Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions. , 2007, Pharmacogenomics.

[4]  B. Winblad,et al.  Apolipoprotein E deficiency increased microglial activation/CCR3 expression and hippocampal damage in kainic acid exposed mice , 2006, Experimental Neurology.

[5]  C. Sudlow,et al.  Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  Chunyan Liu,et al.  Brain edema after intracerebral hemorrhage in rats: the role of inflammation. , 2006, Neurology India.

[7]  M. Ehlers,et al.  Apolipoprotein E Receptor 2 Interactions with the N-Methyl-D-aspartate Receptor* , 2006, Journal of Biological Chemistry.

[8]  M. Vitek,et al.  A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage , 2006, Neurocritical care.

[9]  M. Newman,et al.  APOE polymorphism is associated with risk of severe sepsis in surgical patients* , 2005, Critical care medicine.

[10]  J. Broderick,et al.  Association of Apolipoprotein E4 and Haplotypes of the Apolipoprotein E Gene With Lobar Intracerebral Hemorrhage , 2005, Stroke.

[11]  D. C. Harris,et al.  Multiple pathways of apolipoprotein E signaling in primary neurons , 2005, Journal of neurochemistry.

[12]  M. Vitek,et al.  A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury , 2005, Experimental Neurology.

[13]  D. Schmechel,et al.  Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice , 2004, Neuroscience.

[14]  M. Turina,et al.  Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass. , 2004, The Journal of thoracic and cardiovascular surgery.

[15]  W. Strittmatter,et al.  APOE genotype-specific differences in human and mouse macrophage nitric oxide production , 2004, Journal of Neuroimmunology.

[16]  M. Vitek,et al.  APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response* , 2003, Journal of Biological Chemistry.

[17]  K. Chu,et al.  Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. , 2003, Stroke.

[18]  M. D. Del Bigio,et al.  Comparison of brain cell death and inflammatory reaction in three models of intracerebral hemorrhage in adult rats. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[19]  C. Graffagnino,et al.  Effect of apolipoprotein E genotype on in‐hospital mortality following intracerebral haemorrhage , 2003, Acta neurologica Scandinavica.

[20]  R. Pearlstein,et al.  Protective effect of apolipoprotein E-mimetic peptides on N-methyl-d-aspartate excitotoxicity in primary rat neuronal–glial cell cultures , 2003, Neuroscience.

[21]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[22]  C. Colton,et al.  Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport. , 2001, Biochimica et biophysica acta.

[23]  S. Pizzo,et al.  Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides , 2001, Experimental Neurology.

[24]  Joachim Herz,et al.  Apolipoprotein E receptors: linking brain development and alzheimer's disease , 2000, Nature Reviews Neuroscience.

[25]  A. Saunders,et al.  Intracerebral hemorrhage outcome: Apolipoprotein E genotype, hematoma, and edema volumes , 1999, Neurology.

[26]  P. Froom,et al.  Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injury , 1999, Neurology.

[27]  P. Froom,et al.  Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. , 1999, Neurology.

[28]  N. Maeda,et al.  Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[29]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[30]  J. Garcìa,et al.  Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. , 1995, Stroke.

[31]  B. Pike,et al.  The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. , 1994, Journal of neurotrauma.

[32]  S. Young,et al.  Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. , 1991, The Journal of clinical investigation.

[33]  W. Kyner,et al.  Autoradiographic patterns of brain interstitial fluid flow after collagenase-induced haemorrhage in rat. , 1990, Acta neurochirurgica. Supplementum.